Clinical Trials Browser

Has results × Lenalidomide × Thoracic × Clear all

NCT02963610 2021-12-30

Phase I/II Study of Lenalidomide Plus Pembrolizumab in Patients With Solid Tumors With Expansion in Non-small Cell Lung Cancer

Phase 1/2 Terminated

3 enrolled 5 charts

Carcinoma, Non-Small-Cell Lung, Recurrence